MUCINEX Clinical Study and Survey

Get the Details on MUCINEX Clinical Performance

MUCINEX clinical study and user survey results:

• MUCINEX D was proven in a clinical study to help patients feel better faster when used for symptom relief as an adjunct to an antibiotic in the treatment of an acute respiratory infection (ARI)¹
  Click here for the Antibiotic + MUCINEX D published study
  Click here to learn more about the study and watch a video
  Click here for product information on MUCINEX D



• Did you know patients "MUST HAVE" MUCINEX?
  A consumer survey showed more than 90% of patients were HIGHLY SATISFIED with MUCINEX when used as directed.²
  Click here to learn more about the survey
  Click here for product information on MUCINEX

References: 1. LaForce C, Gentile DA, Skoner DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. Postgrad Med. 2008;120(2):1-7. 2. Storms W, Kaliner MA, Javidi M, Efessiou C, Farrar J. A real-world open-label, multicenter, single-group study to evaluate patients’ reactions to Mucinex (single-entity long-acting guaifenesin). Poster 899. Presented at: 2007 annual meeting of the American Academy of Allergy, Asthma, and Immunology (AAAAI); February 2007; San Diego, CA.

Use as directed.